Related Experiment Videos
Molecular mechanisms in retrovirus DNA integration
1Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Antiviral Research
|February 26, 1998
Summary
Retroviral integrase enzymes insert viral DNA into host genomes. Structural studies and inhibitor screening offer new strategies for developing AIDS antivirals targeting integrase.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Retroviral integrase protein catalyzes viral DNA integration into host cell genomes.
- Integrase activity is modulated in vivo by viral and cellular factors within the pre-integration complex.
- Viral DNA cis-acting sequences at the ends are crucial for integration.
Purpose of the Study:
- To provide a structural basis for understanding retroviral DNA integration.
- To identify and develop novel antiviral strategies targeting integrase for treating retroviral diseases like AIDS.
Main Methods:
- Nuclear Magnetic Resonance (NMR) and X-ray crystallography to solve structures of HIV-1 and ASV integrase domains.
- Screening of various compounds (DNA intercalators, peptides, RNA ligands, organic compounds) for inhibitory effects against HIV-1 integrase.
- Investigating metal-integrase complexes to confirm the role of conserved acidic residues in catalysis.
Main Results:
- Structural insights into integrase N-, C-, and catalytic core domains have been obtained.
- The critical role of the D,D(35)E motif's acidic amino acids in metal-dependent catalysis was confirmed.
- Several classes of compounds showed inhibitory effects against HIV-1 integrase, serving as initial leads for drug development.
Conclusions:
- Structural and biochemical data are advancing the understanding of the retroviral DNA integration mechanism.
- Integrase remains a key target for antiviral drug design against retroviral infections.
- Further development of potent and specific integrase inhibitors is crucial for future AIDS therapies.